胡卜的化学成分,功能性和抗癌性质
Luigi Mandrich1, Antonia Valeria Esposito2, Silvio Costa2
1Research Institute on Terrestrial Ecosystems-IRET-CNR, Via Pietro Castellino 111, 80131 Naples, Italy.
Molecules (Basel, Switzerland)
|October 28, 2023
概括
包括可食用和野生胡卜在内的Daucus carota含有具有抗癌功能的生物活性化合物. 本综述探讨了它们的化学成分和开发新癌症疗法的潜力.
科学领域:
- 植物化学 植物化学
- 药理学 药理学 是一个学科.
- 在瘤学瘤学.
背景情况:
- 植物是抗癌药物的重要来源.
- 达库斯·卡罗塔 (胡卜) 具有多种健康益处.
- 这两种都是食用的 (D. carota L. subsp. ) 和野生 (D. carota L. 亚品种. 胡卜 (胡卜) 亚种具有药用特性.
研究的目的:
- 审查Daucus carota亚种的化学组成和功能性质.
- 在食用和野生胡卜中识别具有抗癌特性的化合物.
- 讨论这些化合物在新型抗癌治疗策略中的潜力.
主要方法:
- 关于Daucus carota化学组成的文献评论.
- 对食用和野生胡卜亚种的功能性质的分析.
- 对抗癌症化合物的鉴定和讨论.
主要成果:
- 可食用胡卜富含胡卜素和食纤维.
- 野生胡卜传统上用于胃,糖尿病和肌肉疼痛.
- 这两种亚种的特定化合物都显示出抗癌潜力.
结论:
- 达库斯·卡罗塔 (Daucus carota) 是抗癌药物开发的一个有前途的来源.
- 对胡卜衍生化合物的进一步研究可以导致新的治疗策略.
- 可食用和野生胡卜两种亚种都需要对其瘤学应用进行研究.
相关概念视频
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Electron Transport Chain: Complex I and II
14.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.2K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K


